Literature DB >> 2076388

Quantitative analysis of antiatherosclerotic effect of nifedipine in cholesterol-fed rabbits.

Y Ohta1, N Higuchi, S Emura, T Takashima, K Oogushi, H Kato, K Ohmori, T Sunaga.   

Abstract

Reports concerning the effect of slow calcium-channel blockers on experimental atherosclerosis are controversial. We examined the antiatherosclerotic effect of nifedipine (40 mg/day for 16 weeks) on aorta of rabbits on diets containing 0.3%, 0.5%, and 1.0% cholesterol. There were no significant differences in levels of serum lipids with or without nifedipine in the same cholesterol-fed rabbits. The results obtained show that nifedipine suppressed the extent of lipid deposition and surface involvement (S.I.) in aorta in 0.3% cholesterol-fed rabbits, whereas nifedipine only tended to suppress S.I. in 0.5% cholesterol-fed rabbits and had no effect in 1.0% cholesterol-fed rabbits. The log dose-response relationship of S.I. was obtained by plotting the concentration of cholesterol in the feed or the "integrated value" of the total serum cholesterol (TC), i.e., the cumulative sum of the serum TC values obtained at each week. The log dose-response curve was shifted in parallel with the right in nifedipine groups. The Lineweaver-Burk plot constructed from the dose-response curve had the same points crossing the ordinate with or without nifedipine. These results suggested that nifedipine suppressed S.I. in a competitive manner with cholesterol on the specific binding site of lipid deposition. Electron-microscopic findings also demonstrated that fat droplets in smooth muscle cells, extracellular matrix containing collagen, and elastic fibers decreased in nifedipine-treated rabbits.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076388     DOI: 10.1007/BF02018311

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  29 in total

1.  Technics for studying atherosclerotic lesions.

Authors:  R L HOLMAN; H C McGILL; J P STRONG; J C GEER
Journal:  Lab Invest       Date:  1958 Jan-Feb       Impact factor: 5.662

2.  Failure of nifedipine to reduce atherogenesis in cholesterol-fed rabbits.

Authors:  M L Overturf; S A Smith
Journal:  Artery       Date:  1986

3.  Flordipine, a calcium channel blocker, which does not influence lipidemia or atherosclerosis in cholesterol-fed rabbits.

Authors:  D Kritchevsky; S A Tepper; D M Klurfeld
Journal:  Atherosclerosis       Date:  1988-01       Impact factor: 5.162

4.  The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis.

Authors:  I Y Rosenblum; L Flora; R Eisenstein
Journal:  Atherosclerosis       Date:  1975 Nov-Dec       Impact factor: 5.162

5.  Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.

Authors:  D M Kramsch; A J Aspen; C S Apstein
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

6.  Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.

Authors:  O R Etingin; D P Hajjar
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

7.  Verapamil suppresses atherosclerosis in cholesterol-fed rabbits.

Authors:  J L Rouleau; W W Parmley; J Stevens; J Wikman-Coffelt; R Sievers; R W Mahley; R J Havel
Journal:  J Am Coll Cardiol       Date:  1983-06       Impact factor: 24.094

8.  Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits.

Authors:  M Naito; F Kuzuya; K Asai; K Shibata; N Yoshimine
Journal:  Angiology       Date:  1984-10       Impact factor: 3.619

9.  Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.

Authors:  O Stein; E Leitersdorf; Y Stein
Journal:  Arteriosclerosis       Date:  1985 Jan-Feb

10.  Practical stereological methods for morphometric cytology.

Authors:  E R Weibel; G S Kistler; W F Scherle
Journal:  J Cell Biol       Date:  1966-07       Impact factor: 10.539

View more
  1 in total

Review 1.  Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.

Authors:  S Jost; W Rafflenbeul; J Deckers; B Wiese; H Hecker; P Nikutta; P Lippolt; P Lichtlen
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.